95 results on '"Schölch S"'
Search Results
2. Arid1a mutation promotes cell proliferation and invasion, and leads to broad drug resistance in colorectal cancer
- Author
-
Jin, F., additional, Betge, J., additional, Reißfelder, C., additional, Zhu, L., additional, and Schölch, S., additional
- Published
- 2023
- Full Text
- View/download PDF
3. Antibiotische Therapie vs. Appendektomie bei nichtperforierter Appendizitis im Erwachsenenalter
- Author
-
Schölch, S. and Reißfelder, C.
- Published
- 2019
- Full Text
- View/download PDF
4. 174P Pulmonary tuft cell-like cancers across different histotypes share molecular features with potentially druggable vulnerabilities
- Author
-
Yamada, Y., primary, Bohnenberger, H., additional, Kriegsmann, M., additional, Kriegsmann, K., additional, Schölch, S., additional, Ströbel, P., additional, and Marx, A., additional
- Published
- 2022
- Full Text
- View/download PDF
5. Comparing the outcome of proton beam irradiation with experimental x-ray and clinical photons in a sophisticated 3-D assay setup
- Author
-
Sorour, N., Hussein, R., Neubeck, C., Lühr, A., Schölch, S., Beyreuther, E., Pawelke, J., and Kunz-Schughart, L. A.
- Abstract
Background and Aim: Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer with a median survival of
- Published
- 2018
6. Antibiotische Therapie vs. Appendektomie bei nichtperforierter Appendizitis im Erwachsenenalter
- Author
-
Schölch, S., primary and Reißfelder, C., additional
- Published
- 2018
- Full Text
- View/download PDF
7. Eine orale VEGFR-2-Vakzine in Kombination mit Checkpoint-Inhibition im genetisch induzierten Mausmodell des kolorektalen Karzinoms
- Author
-
Betzler, AM, additional, Kochall, S, additional, Schmitz-Winnenthal, H, additional, Weitz, J, additional, Reissfelder, C, additional, and Schölch, S, additional
- Published
- 2017
- Full Text
- View/download PDF
8. Funktionelle und molekulare Charakterisierung zirkulierender Tumorzellen im genetisch induzierten Mausmodell des kolorektalen Karzinoms
- Author
-
Schölch, S, additional, Nanduri, LK, additional, García, SA, additional, Kochall, S, additional, Thepkaysone, ML, additional, Betzler, AM, additional, Rahbari, NN, additional, Weitz, J, additional, and Reißfelder, C, additional
- Published
- 2017
- Full Text
- View/download PDF
9. Etablierung und Charakterisierung von Organoidlinien des cholangiozellulären Karzinoms
- Author
-
Kühn, D, additional, Nanduri, LK, additional, Thepkaysone, ML, additional, Kochall, S, additional, Thiede, C, additional, Weitz, J, additional, Reissfelder, C, additional, and Schölch, S, additional
- Published
- 2017
- Full Text
- View/download PDF
10. How we significantly reduced oesophagectomy leaks and the significance of Mean Arterial Pressure
- Author
-
Reissfelder, C, additional, Mees, T, additional, Schölch, S, additional, Remer, A, additional, Seifert, A, additional, and Weitz, J, additional
- Published
- 2017
- Full Text
- View/download PDF
11. Die Rolle von DLG7/DLGAP5 in Pankreas- und Kolonkarzinom
- Author
-
Branchi, V, additional, Garcia, SA, additional, Radhakrishnan, P, additional, Ulrich, A, additional, Schneider, M, additional, Büchler, MW, additional, Weitz, J, additional, Reißfelder, C, additional, and Schölch, S, additional
- Published
- 2017
- Full Text
- View/download PDF
12. The Combination of Ionizing Radiation and Toll-Like Receptor 7/8 Agonists Creates Local and Abscopal Tumor Immune Responses In Vivo
- Author
-
Nicolay, N.H., primary, Schölch, S., additional, Rauber, C., additional, Lopez Perez, R., additional, Debus, J., additional, and Huber, P.E., additional
- Published
- 2016
- Full Text
- View/download PDF
13. Interleukin-3 amplifies acute inflammation in sepsis
- Author
-
Weber, GF, primary, Chousterman, BG, additional, He, S, additional, Fenn, AM, additional, Nairz, M, additional, Anzai, A, additional, Brenner, T, additional, Uhle, F, additional, Iwamoto, Y, additional, Robbins, CS, additional, Noiret, L, additional, Maier, SL, additional, Zönnchen, T, additional, Rahbari, NN, additional, Schölch, S, additional, Klotzsche-von Ameln, A, additional, Chavakis, T, additional, Weitz, J, additional, Hofer, S, additional, Weigand, MA, additional, Nahrendorf, M, additional, Weissleder, R, additional, and Swirski, FK, additional
- Published
- 2016
- Full Text
- View/download PDF
14. Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study
- Author
-
Bork, U, primary, Rahbari, N N, additional, Schölch, S, additional, Reissfelder, C, additional, Kahlert, C, additional, Büchler, M W, additional, Weitz, J, additional, and Koch, M, additional
- Published
- 2015
- Full Text
- View/download PDF
15. 196 Neuropilin 2 (NRP2) modifies CXCL12/CXCR4 signaling and promotes lymph node metastases in colon cancer
- Author
-
Schneider, H., primary, Hönscheid, P., additional, Schölch, S., additional, Jakob, C., additional, and Muders, M., additional
- Published
- 2014
- Full Text
- View/download PDF
16. Etablierung eines Magen-Tumormodells ausgehend von der Troy+ Magen-Stammzelle
- Author
-
Stange, DE, primary, Kempe, A, additional, Schölch, S, additional, and Weitz, J, additional
- Published
- 2014
- Full Text
- View/download PDF
17. Isolierung und Charakterisierung von zirkulierenden Tumorzellen in einem orthotopen kolorektalen Mausmodell
- Author
-
Schölch, S, primary, Swiersy, A, additional, Iwata, N, additional, Niemietz, T, additional, García, SA, additional, Betzler, AM, additional, Bork, U, additional, Rahbari, NN, additional, Kahlert, C, additional, Stange, DE, additional, Weitz, J, additional, and Koch, M, additional
- Published
- 2014
- Full Text
- View/download PDF
18. Triple Therapy of Radiation and Combined Integrin and EGFR Blockade in an Orthotopic Glioblastoma Model
- Author
-
Roehrich, M., primary, Fiedler, S., additional, Zhang, M., additional, Capper, D., additional, Trinh, T., additional, Jenne, J., additional, Schölch, S., additional, and Huber, P., additional
- Published
- 2012
- Full Text
- View/download PDF
19. Combining Integrin Inhibition (Cilengitide), EGFR Inhibition (Cetuximab) and Radiation in a Pancreatic Cancer Model
- Author
-
Timke, C., Fritz, E., Schoelch, S., Roeder, F., Abdollahi, A., Debus, J., Koch, M., Goodmann, S., and Huber, P.E.
- Published
- 2010
- Full Text
- View/download PDF
20. Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors
- Author
-
Schölch S, Rauber C, Tietz A, Nn, Rahbari, Bork U, Thomas Schmidt, Kahlert C, Haberkorn U, Ma, Tomai, Ke, Lipson, Carretero R, Weitz J, Koch M, and Pe, Huber
21. [Gender-specific differences in bariatric surgery: epidemiology, treatment and results].
- Author
-
Téoule P, Pozek E, Hielscher T, Reißfelder C, Stier C, Otto M, and Schölch S
- Subjects
- Humans, Male, Female, Adult, Middle Aged, Retrospective Studies, Treatment Outcome, Body Mass Index, Sex Factors, Germany epidemiology, Postoperative Complications epidemiology, Postoperative Complications etiology, Bariatric Surgery statistics & numerical data, Bariatric Surgery adverse effects, Obesity, Morbid surgery, Obesity, Morbid epidemiology
- Abstract
This study investigates gender-specific differences in obesity and the treatment by metabolic bariatric surgery (MBS). The database includes 2393 patients (1725 women, 668 men) from for a high-volume center for bariatric surgery. Demographic, perioperative and follow-up data were retrospectively analyzed. Men had a significantly higher body mass index (BMI) and more frequent obesity-associated diseases. Despite the higher prevalence of obesity in men, women accounted for 80% of the surgical patients. On average men had longer operation times but with the same complication rates. Postoperatively, both sexes experienced a significant reduction in excess body weight, which was slightly more pronounced in women. The study particularly emphasizes the need to better motivate men to undergo obesity treatment in order to reduce the health consequences of morbid obesity in this population group., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
22. Implementation of a multimodal home-based rehabilitation intervention after discharge from inpatient geriatric rehabilitation (GeRas): an early qualitative process evaluation.
- Author
-
Roth C, Maier L, Abel B, Roigk P, Rapp K, Schmidberger O, Bongartz M, Maier S, Wirth I, Metz B, Immel D, Finger B, Schölch S, Büchele G, Deuster O, Koenig HH, Gottschalk S, Dams J, Micol W, Bauer JM, Wensing M, and Benzinger P
- Subjects
- Humans, Aged, Male, Female, Aged, 80 and over, Qualitative Research, Inpatients, Patient Discharge, Home Care Services
- Abstract
Background: Geriatric rehabilitation aims at increasing physical and social activity and maintaining the functional reserve of older people. However, the continuity of geriatric rehabilitation in the outpatient setting is limited due to a lack of structured aftercare programs. In order to overcome this, a three-month multimodal home-based intervention program (GeRas) was implemented. The aim of this early qualitative process evaluation was to assess GeRas in terms of perceived reach, effectiveness/efficacy, adoption/uptake, implementation, and maintenance/sustainability (Domains within the RE-AIM Framework) from the perspective of patients who received the intervention and healthcare providers who were involved in the delivery of the intervention., Methods: In a qualitative process evaluation, 13 healthcare providers and 10 patients were interviewed throughout the beginning of the implementation period of GeRas to capture early experiences using a semi-structured interview guide. The interview guide and qualitative content analysis was guided by the RE-AIM Framework., Results: The GeRas program was perceived to be largely well implemented and beneficial by healthcare providers and patients. According to healthcare providers, GeRas showed more advantages compared to usual care. Additionally, outcome expectations were mainly met (Domain 1: Effectiveness). However, the implementation of the intervention delivered via the eHealth system was perceived as challenging (Domain 2: Adoption). Nevertheless, the outpatient physical exercise, the outpatient counselling, and the continuous care after discharge improved perceived well-being regardless of the intervention type (Domain 3: Implementation). To facilitate the continued use of GeRas, technical requirements should be created to increase user-friendliness and to motivate patients to continue the training in the long term (Domain 4: Maintenance)., Conclusion: Although initial experiences with the implementation and effectiveness of GeRas were positive in general, organisational and technical issues need to be resolved to enhance sustainable and successful implementation of the GeRas program., Trial Registration: German Clinical Trials Register (DRKS00029559). Registered 5/10/2022., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
23. The role of patient-related factors in the implementation of a multimodal home-based rehabilitation intervention after discharge from inpatient geriatric rehabilitation (GeRas): a qualitative process evaluation.
- Author
-
Maier L, Benzinger P, Abel B, Roigk P, Bongartz M, Wirth I, Cuvelier I, Schölch S, Büchele G, Deuster O, Bauer J, Rapp K, Ullrich C, Wensing M, and Roth C
- Abstract
Background: Structured aftercare programs are implemented to facilitate the transition from rehabilitation centers to patients' home environments. Taking the program GeRas as an example, this paper aims to evaluate the influence of patient-related factors on the implementation of the geriatric aftercare program GeRas from patients' and providers' perspectives., Methods: To capture patients' and providers' perspectives, qualitative interviews were conducted using a semi-structured interview guide. The analysis was inductive-deductive and based on the thematic analysis by Braun and Clarke and guided by Domain IV of the CFIR., Results: 16 participants (10 patients, 4 providers, 2 family members) were interviewed from May 2023 to November 2023. Patient-related factors were perceived as an important aspect during the implementation of the GeRas program. The results were allocated to the four Constructs of Domain IV of the CFIR (Motivation, Opportunity, Capability, Needs). Especially patients' intrinsic motivation, social environment, and physical capabilities seemed to be crucial for successful implementation. While extrinsic motivation can mitigate missing personal capabilities, it cannot replace the presence of intrinsic motivation and capabilities. The results showed that patient-related factors are interlinked., Discussion/conclusion: The relevance of patient-related factors during the implementation of the GeRas program shows that such programs must consider these factors during intervention planning., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
24. Weekday-dependent long-term outcomes in gastrointestinal cancer surgery: a German population-based retrospective cohort study.
- Author
-
Maier CF, Schölch C, Zhu L, Nzomo MM, L'hoest H, Marschall U, Reißfelder C, and Schölch S
- Subjects
- Humans, Retrospective Studies, Postoperative Complications epidemiology, Postoperative Complications etiology, Gastrointestinal Neoplasms surgery, Digestive System Surgical Procedures adverse effects, Colorectal Neoplasms
- Abstract
Background: For most solid cancers, surgery represents the mainstay of curative treatment. Several studies investigating the effects of the weekday of surgery (WOS) on patient outcomes have yielded conflicting results. Barmer, the second-largest health insurance company in Germany, serves roughly 10% of the German population. The authors have used the Barmer database to evaluate how the weekday on which the surgery is performed influences long-term oncologic outcomes., Methods: For this retrospective cohort study, the Barmer database was used to investigate the effect of the WOS (Monday-Friday) on outcomes following oncological resections of the colorectum ( n =49 003), liver ( n =1302), stomach ( n =5027), esophagus ( n =1126), and pancreas ( n =6097). In total, 62 555 cases from 2008 to 2018 were included in the analysis. The endpoints were overall survival (OS), postoperative complications, and the necessity for therapeutic interventions or reoperations. The authors further examined whether the annual caseload or certification as a cancer center influenced the weekday effect., Results: The authors observed a significantly impaired OS for patients receiving gastric or colorectal resections on a Monday. Colorectal surgery performed on Mondays was associated with more postoperative complications and a higher probability of reoperations. The annual caseload or a certification as a colorectal cancer center had no bearing on the observed weekday effect. There is evidence that hospitals schedule older patients with more comorbidities earlier in the week, possibly explaining these findings., Conclusion: This is the first study investigating the influence of the WOS on long-term survival in Germany. Our findings indicate that, in the German healthcare system, patients undergoing colorectal cancer surgery on Mondays have more postoperative complications and, therefore, require significantly more reoperations, ultimately lowering the OS. This surprising finding appears to reflect an attempt to schedule patients with higher postoperative risk earlier in the week as well as semi-elective patients admitted on weekends scheduled for surgery on the next Monday., (Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2023
- Full Text
- View/download PDF
25. ARID1A mutations in lung cancer: biology, prognostic role, and therapeutic implications.
- Author
-
Jin F, Yang Z, Shao J, Tao J, Reißfelder C, Loges S, Zhu L, and Schölch S
- Subjects
- Humans, Transcription Factors genetics, Transcription Factors metabolism, Nuclear Proteins genetics, Nuclear Proteins metabolism, Prognosis, Mutation, ErbB Receptors genetics, Biology, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, Lung Neoplasms drug therapy, Lung Neoplasms genetics
- Abstract
Mutations in the AT-interacting domain-rich protein 1A (ARID1A) gene, a critical component of the switch/sucrose nonfermentable (SWI/SNF) complex, are frequently found in most human cancers. Approximately 5-10% of lung cancers carry ARID1A mutations. ARID1A loss in lung cancer correlates with clinicopathological features and poor prognosis. Co-mutation of ARID1A and epidermal growth factor receptor (EGFR) results in the limited efficacy of EGFR tyrosine kinase inhibitors (EGFR-TKIs) but increases the clinical benefit of immune checkpoint inhibitors (ICIs). ARID1A gene mutation plays a role in cell cycle regulation, metabolic reprogramming, and epithelial-mesenchymal transition. We present the first comprehensive review of the relationship between ARID1A gene mutations and lung cancer and discuss the potential of ARID1A as a new molecular target., Competing Interests: Declaration of interests S.L. has received research support from BerGenBio, Bristol Myers Squibb, Eli Lilly and Company, Roche, and ADC Therapeutics. S.L. has received speaker honoraria from BerGenBio, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly and Company, Roche, Medac, Sanofi Aventis, Novartis, AstraZeneca, Pfizer, Takeda Pharmaceutical Company, Amgen, Bayer, Janssen Pharmaceuticals, and Merck. S.L. is consultant to BerGenBio, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly and Company, Roche, Medac, Sanofi Aventis, Novartis, AstraZeneca, Pfizer, Takeda Pharmaceutical Company, Amgen, Bayer, Janssen Pharmaceuticals, and Merck. S.L. has received travel support from BerGenBio, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly and Company, Roche, Medac, Sanofi Aventis, Novartis, AstraZeneca, Pfizer, Takeda Pharmaceutical Company, Amgen, Bayer, Janssen Pharmaceuticals, and Merck. Author S.L. has received drugs for research from Bristol Myers Squibb. All other authors have no financial or any other competing interests., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
26. Primary tumor-derived systemic nANGPTL4 inhibits metastasis.
- Author
-
Hübers C, Abdul Pari AA, Grieshober D, Petkov M, Schmidt A, Messmer T, Heyer CM, Schölch S, Kapel SS, Gengenbacher N, Singhal M, Schieb B, Fricke C, Will R, Remans K, Utikal JS, Reissfelder C, Schlesner M, Hodivala-Dilke KM, Kersten S, Goerdt S, Augustin HG, and Felcht M
- Subjects
- Humans, Angiopoietins pharmacology, Angiopoietins therapeutic use, Biomarkers, Tumor, Peptide Fragments pharmacology, Peptide Fragments therapeutic use, Angiopoietin-Like Protein 4 pharmacology, Angiopoietin-Like Protein 4 therapeutic use, Neoplasms diagnosis, Neoplasms drug therapy, Neoplasms metabolism
- Abstract
Primary tumors and distant site metastases form a bidirectionally communicating system. Yet, the molecular mechanisms of this crosstalk are poorly understood. Here, we identified the proteolytically cleaved fragments of angiopoietin-like 4 (ANGPTL4) as contextually active protumorigenic and antitumorigenic contributors in this communication ecosystem. Preclinical studies in multiple tumor models revealed that the C-terminal fragment (cANGPTL4) promoted tumor growth and metastasis. In contrast, the N-terminal fragment of ANGPTL4 (nANGPTL4) inhibited metastasis and enhanced overall survival in a postsurgical metastasis model by inhibiting WNT signaling and reducing vascularity at the metastatic site. Tracing ANGPTL4 and its fragments in tumor patients detected full-length ANGPTL4 primarily in tumor tissues, whereas nANGPTL4 predominated in systemic circulation and correlated inversely with disease progression. The study highlights the spatial context of the proteolytic cleavage-dependent pro- and antitumorigenic functions of ANGPTL4 and identifies and validates nANGPTL4 as a novel biomarker of tumor progression and antimetastatic therapeutic agent., (© 2022 Hübers et al.)
- Published
- 2023
- Full Text
- View/download PDF
27. Lumbar Spondylodiscitis Mimicking Cholecystitis: A Case Report and Review of Literature.
- Author
-
Mirbagheri A, Etminan N, Schölch S, Maier C, Perrin J, and Enders F
- Subjects
- Male, Female, Humans, Aged, Lumbar Vertebrae diagnostic imaging, Abdominal Pain complications, Abdominal Pain drug therapy, Anti-Bacterial Agents therapeutic use, Magnetic Resonance Imaging adverse effects, Discitis diagnostic imaging, Discitis etiology, Low Back Pain drug therapy, Clinical Deterioration, Cholecystitis complications, Cholecystitis drug therapy
- Abstract
Background: Lower back pain is a frequent cause of emergency department visits and one of the leading causes of the disease burden worldwide. The purpose of this case report and literature review was to discuss atypical abdominal entities mimicking spinal diseases typically presenting with lower back pain., Methods: A 79-year-old man presented with lower back pain and urinary incontinence after receiving a non-image-guided lumbar infiltration treatment 4 weeks prior to admission. The magnetic resonance imaging (MRI) highlighted multisegmental hyperintensities in the intervertebral disk spaces of the lumbar spine indicative for spondylodiscitis. Antibiotic treatment over a week did not lead to significant clinical improvement. Blood cultures, cardiologic, otorhinolaryngologic, and dental examinations turned out negative for a focus of infection. A computed tomography (CT) guided biopsy was indicated after discontinuation of antibiotic treatment for less than 24 hours. Rapid clinical deterioration with concomitant onset of abdominal pain resulted in the diagnosis of cholecystitis, which required cholecystectomy. We performed a systematic literature review using the Pubmed database for the keywords "spondylodiscitis," "spine," "abdominal," and "cholecystitis," to identify abdominal diseases that mimic spine pathologies and spinal diseases that mimic abdominal pathologies., Results: No other report in English literature of cholecystitis associated with initial onset of lower back pain was identified. Eighteen reports referred to abdominal conditions that mimic spinal diseases, among them a patient with cyclic lumbar back pain who received a lumbar spinal fusion who, after persisting symptoms led to further diagnostic procedures, was ultimately diagnosed with endometriosis. Spinal symptoms included paraplegia and urinary incontinence as results of acute aortic pathologies. Eleven reports presented spinal pain mimicking abdominal conditions including abdominal pain and diarrhea as well as have had surgical procedures such as an appendectomy before the spinal condition was discovered., Conclusion: Clinical symptoms of the spine such as lower back pain can be unspecific and lead to false conclusions in the presence of concomitant pathologies in MRI. Only clinical deterioration in our case patient prompted correction of the diagnosis on day 7. Initial workup for alternative common infectious foci such as lung and urinary tract was performed, but further abdominal workup despite the absence of abdominal symptoms may have led to an earlier diagnosis. Our literature review found several cases of misdiagnosed spinal and abdominal conditions. Some had undergone unnecessary surgical procedures before the right diagnosis was made. Because of the high incidence of symptoms such as lumbar back pain and abdominal pain, considering optimal patient care as well as economic aspects, it would be essential to conduct an interdisciplinary clinical management to avoid errors in the early stage of diagnostics., Competing Interests: None declared., (Thieme. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
28. Circulating tumour cells in patients with lung cancer universally indicate poor prognosis.
- Author
-
Jin F, Zhu L, Shao J, Yakoub M, Schmitt L, Reißfelder C, Loges S, Benner A, and Schölch S
- Subjects
- Humans, Prognosis, Biomarkers, Tumor, Neoplastic Cells, Circulating pathology, Lung Neoplasms pathology, Carcinoma, Non-Small-Cell Lung
- Abstract
Background: In lung cancer, the relevance of various circulating tumour cell (CTC) subgroups in different lung cancer subtypes is unclear. We performed a comprehensive meta-analysis to assess the prognostic value of CTCs in the different histological types of lung cancer, with particular respect to CTC subtypes, cut-offs and time points of CTC enumeration., Methods: We searched MEDLINE, Web of Science and Embase alongside relevant studies evaluating the prognostic value of CTCs in lung cancer patients. A random-effects model was used for meta-analysis, calculating hazard ratios (HRs), 95% confidence intervals and p-values., Results: 27 studies enrolling 2957 patients were included. CTC detection indicates poor prognosis, especially in small cell lung cancer (SCLC) patients (overall survival HR 3.11, 95% CI 2.59-3.73) and predicts a worse outcome compared to nonsmall cell lung cancer patients. Epithelial CTCs predict a worse outcome for lung cancer than mesenchymal CTCs or epithelial-mesenchymal hybrids., Conclusion: CTCs indicate poor prognosis in patients with primary lung cancer, with CTCs in SCLC having a more pronounced prognostic effect. The prognostic value of CTCs detected by different markers varies; most evidence is available for the strong negative prognostic effect of epithelial CTCs., Competing Interests: Conflict of interest: S. Loges reports grants and personal fees from BerGenBio AS, BMS, and Roche, and personal fees from Lilly, Sanofi, Novartis, Boehringer Ingelheim, AstraZeneca, MSD, Sanofi Aventis, Janssen, Takeda and Daiichi-Sankyo outside the submitted work. The other authors reported no disclosures., (Copyright ©The authors 2022.)
- Published
- 2022
- Full Text
- View/download PDF
29. Prognostic value of primary tumor sidedness in patients with non-metastatic IBD related CRC - Is it the exception to the rule?
- Author
-
Kamphues C, Lefevre JH, Wang J, Amini N, Beaugerie L, Kuehn F, Park SH, Andreatos N, Lauscher JC, Enea D, Lehmann KS, Peru N, Weixler B, Kirchgesner J, Degro CE, Pozios I, van Beekum CJ, Schölch S, Zambonin D, Schineis C, Loch FN, Geka D, Theoxari M, Wu B, Wang PP, Antoniou E, Pikoulis E, Moussata D, Theodoropoulos G, Ouaissi M, Seeliger H, Inaba Y, Scaringi S, Reißfelder C, Vilz TO, Lin C, Yang SK, Beyer K, Renz BW, Sasaki K, Margonis GA, Svrcek M, and Kreis ME
- Subjects
- Humans, Prognosis, Retrospective Studies, Colorectal Neoplasms pathology, Rectal Neoplasms, Inflammatory Bowel Diseases
- Abstract
Background: Although primary tumor sidedness (PTS) has a known prognostic role in sporadic colorectal cancer (CRC), its role in Inflammatory Bowel Disease related CRC (IBD-CRC) is largely unknown. Thus, we aimed to evaluate the prognostic role of PTS in patients with IBD-CRC., Methods: All eligible patients with surgically treated, non-metastatic IBD-CRC were retrospectively identified from institutional databases at ten European and Asian academic centers. Long term endpoints included recurrence-free (RFS) and overall survival (OS). Multivariable Cox proportional hazard regression as well as propensity score analyses were performed to evaluate whether PTS was significantly associated with RFS and OS., Results: A total of 213 patients were included in the analysis, of which 32.4% had right-sided (RS) tumors and 67.6% had left-sided (LS) tumors. PTS was not associated with OS and RFS even on univariable analysis (5-year OS for RS vs LS tumors was 68.0% vs 77.3%, respectively, p = 0.31; 5-year RFS for RS vs LS tumors was 62.8% vs 65.4%, respectively, p = 0.51). Similarly, PTS was not associated with OS and RFS on propensity score matched analysis (5-year OS for RS vs LS tumors was 82.9% vs 91.3%, p = 0.79; 5-year RFS for RS vs LS tumors was 85.1% vs 81.5%, p = 0.69). These results were maintained when OS and RFS were calculated in patients with RS vs LS tumors after excluding patients with rectal tumors (5-year OS for RS vs LS tumors was 68.0% vs 77.2%, respectively, p = 0.38; 5-year RFS for RS vs LS tumors was 62.8% vs 59.2%, respectively, p = 0.98)., Conclusions: In contrast to sporadic CRC, PTS does not appear to have a prognostic role in IBD-CRC., Competing Interests: Declaration of competing interest None., (Copyright © 2022 Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
30. Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities.
- Author
-
Yamada Y, Belharazem-Vitacolonnna D, Bohnenberger H, Weiß C, Matsui N, Kriegsmann M, Kriegsmann K, Sinn P, Simon-Keller K, Hamilton G, Graeter T, Preissler G, Ott G, Schölch S, Nakajima N, Yoshizawa A, Haga H, Date H, Thomas RK, Petrini I, Giaccone G, Ströbel P, and Marx A
- Subjects
- Humans, Proto-Oncogene Proteins c-bcl-2 genetics, Forkhead Transcription Factors, Lung Neoplasms pathology, Carcinoma, Large Cell genetics, Carcinoma, Small Cell metabolism, Carcinoma, Small Cell pathology, Carcinoma, Neuroendocrine genetics, Carcinoma, Neuroendocrine metabolism, Carcinoma, Neuroendocrine pathology, Carcinoma, Squamous Cell pathology
- Abstract
Tuft cells are chemosensory epithelial cells in the respiratory tract and several other organs. Recent studies revealed tuft cell-like gene expression signatures in some pulmonary adenocarcinomas, squamous cell carcinomas (SQCC), small cell carcinomas (SCLC), and large cell neuroendocrine carcinomas (LCNEC). Identification of their similarities could inform shared druggable vulnerabilities. Clinicopathological features of tuft cell-like (tcl) subsets in various lung cancer histotypes were studied in two independent tumor cohorts using immunohistochemistry (n = 674 and 70). Findings were confirmed, and additional characteristics were explored using public datasets (RNA seq and immunohistochemical data) (n = 555). Drug susceptibilities of tuft cell-like SCLC cell lines were also investigated. By immunohistochemistry, 10-20% of SCLC and LCNEC, and approximately 2% of SQCC expressed POU2F3, the master regulator of tuft cells. These tuft cell-like tumors exhibited "lineage ambiguity" as they co-expressed NCAM1, a marker for neuroendocrine differentiation, and KRT5, a marker for squamous differentiation. In addition, tuft cell-like tumors co-expressed BCL2 and KIT, and tuft cell-like SCLC and LCNEC, but not SQCC, also highly expressed MYC. Data from public datasets confirmed these features and revealed that tuft cell-like SCLC and LCNEC co-clustered on hierarchical clustering. Furthermore, only tuft cell-like subsets among pulmonary cancers significantly expressed FOXI1, the master regulator of ionocytes, suggesting their bidirectional but immature differentiation status. Clinically, tuft cell-like SCLC and LCNEC had a similar prognosis. Experimentally, tuft cell-like SCLC cell lines were susceptible to PARP and BCL2 co-inhibition, indicating synergistic effects. Taken together, pulmonary tuft cell-like cancers maintain histotype-related clinicopathologic characteristics despite overlapping unique molecular features. From a therapeutic perspective, identification of tuft cell-like LCNECs might be crucial given their close kinship with tuft cell-like SCLC., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
31. Robot-assisted esophagectomy may improve perioperative outcome in patients with esophageal cancer - a single-center experience.
- Author
-
Betzler J, Elfinger L, Büttner S, Weiß C, Rahbari N, Betzler A, Reißfelder C, Otto M, Blank S, and Schölch S
- Abstract
Background: Although the introduction of minimally invasive surgical techniques has improved surgical outcomes in recent decades, esophagectomy for esophageal cancer is still associated with severe complications and a high mortality rate. Robot-assisted surgery is already established in certain fields and robot-assisted esophagectomy may be a possible alternative to the standard minimally invasive esophagectomy. The goal of this study was to investigate whether robot assistance in esophagectomy can improve patient outcome while maintaining good oncological control., Material and Methods: Data of all patients who underwent minimally invasive esophagectomy between January 2018 and November 2021 at University Hospital Mannheim was collected retrospectively. Patients were divided into two cohorts according to operative technique (standard minimally invasive (MIE) vs. robot-assisted esophagectomy (RAMIE), and their outcomes compared. In a separate analysis, patients were propensity score matched according to age, gender and histological diagnosis, leading to 20 matching pairs., Results: 95 patients were included in this study. Of those, 71 patients underwent robot-assisted esophagectomy and 24 patients underwent standard minimally invasive esophagectomy. Robot-assisted esophagectomy showed a lower incidence of general postoperative complications (52.1% vs. 79.2%, p=0.0198), surgical complications (42.3% vs. 75.0%, p=0.0055), a lower rate of anastomotic leakage (21.1% vs. 50.0%, p=0.0067), a lower Comprehensive Complication Index (median of 20.9 vs. 38.6, p=0.0065) as well as a shorter duration of hospital stay (median of 15 vs. 26 days, p=0.0012) and stay in the intensive care unit (median of 4 vs. 7 days, p=0.028) than standard minimally invasive surgery. After additionally matching RAMIE and MIE patients according to age, gender and diagnosis, we found significant improvement in the RAMIE group compared to the MIE group regarding the Comprehensive Complication Index (median of 20.9 vs. 38.6, p=0.0276), anastomotic leakage (20% vs. 55%, p=0.0484) and severe toxicity during neoadjuvant treatment (0 patients vs. 9 patients, p=0.005)., Conclusion: Robot-assisted surgery can significantly improve outcomes for patients with esophageal cancer. It may lead to a shorter hospital stay as well as lower rates of complications, including anastomotic leakage., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Betzler, Elfinger, Büttner, Weiß, Rahbari, Betzler, Reißfelder, Otto, Blank and Schölch.)
- Published
- 2022
- Full Text
- View/download PDF
32. Cell-Cell Interactions Drive Metastasis of Circulating Tumor Microemboli.
- Author
-
Tao J, Zhu L, Yakoub M, Reißfelder C, Loges S, and Schölch S
- Subjects
- Cell Communication, Humans, Neoplasm Metastasis pathology, Stromal Cells pathology, Neoplastic Cells, Circulating pathology
- Abstract
Circulating tumor cells are the cellular mediators of distant metastasis in solid malignancies. Their metastatic potential can be augmented by clustering with other tumor cells or nonmalignant cells, forming circulating tumor microemboli (CTM). Cell-cell interactions are key regulators within CTM that convey enhanced metastatic properties, including improved cell survival, immune evasion, and effective extravasation into distant organs. However, the cellular and molecular mechanism of CTM formation, as well as the biology of interactions between tumor cells and immune cells, platelets, and stromal cells in the circulation, remains to be determined. Here, we review the current literature on cell-cell interactions in homotypic and heterotypic CTM and provide perspectives on therapeutic strategies to attenuate CTM-mediated metastasis by targeting cell-cell interactions., (©2022 American Association for Cancer Research.)
- Published
- 2022
- Full Text
- View/download PDF
33. Comparative Study of the Role of Interepithelial Mucosal Mast Cells in the Context of Intestinal Adenoma-Carcinoma Progression.
- Author
-
Groll T, Silva M, Sarker RSJ, Tschurtschenthaler M, Schnalzger T, Mogler C, Denk D, Schölch S, Schraml BU, Ruland J, Rad R, Saur D, Weichert W, Jesinghaus M, Matiasek K, and Steiger K
- Abstract
Mast cells (MCs) are crucial players in the relationship between the tumor microenvironment (TME) and cancer cells and have been shown to influence angiogenesis and progression of human colorectal cancer (CRC). However, the role of MCs in the TME is controversially discussed as either pro- or anti-tumorigenic. Genetically engineered mouse models (GEMMs) are the most frequently used in vivo models for human CRC research. In the murine intestine there are at least three different MC subtypes: interepithelial mucosal mast cells (ieMMCs), lamina proprial mucosal mast cells (lpMMCs) and connective tissue mast cells (CTMCs). Interepithelial mucosal mast cells (ieMMCs) in (pre-)neoplastic intestinal formalin-fixed paraffin-embedded (FFPE) specimens of mouse models (total lesions n = 274) and human patients (n = 104) were immunohistochemically identified and semiquantitatively scored. Scores were analyzed along the adenoma-carcinoma sequence in humans and 12 GEMMs of small and large intestinal cancer. The presence of ieMMCs was a common finding in intestinal adenomas and carcinomas in mice and humans. The number of ieMMCs decreased in the course of colonic adenoma-carcinoma sequence in both species (p < 0.001). However, this dynamic cellular state was not observed for small intestinal murine tumors. Furthermore, ieMMC scores were higher in GEMMs with altered Wnt signaling (active β-catenin) than in GEMMs with altered MAPK signaling and wildtypes (WT). In conclusion, we hypothesize that, besides stromal MCs (lpMMCs/CTMCs), particularly the ieMMC subset is important for onset and progression of intestinal neoplasia and may interact with the adjacent neoplastic epithelial cells in dependence on the molecular environment. Moreover, our study indicates the need for adequate GEMMs for the investigation of the intestinal immunologic TME.
- Published
- 2022
- Full Text
- View/download PDF
34. Metabolic Profiling of Thymic Epithelial Tumors Hints to a Strong Warburg Effect, Glutaminolysis and Precarious Redox Homeostasis as Potential Therapeutic Targets.
- Author
-
Alwahsh M, Knitsch R, Marchan R, Lambert J, Hoerner C, Zhang X, Schalke B, Lee DH, Bulut E, Graeter T, Ott G, Kurz KS, Preissler G, Schölch S, Farhat J, Yao Z, Sticht C, Ströbel P, Hergenröder R, Marx A, and Belharazem D
- Abstract
Thymomas and thymic carcinomas (TC) are malignant thymic epithelial tumors (TETs) with poor outcome, if non-resectable. Metabolic signatures of TETs have not yet been studied and may offer new therapeutic options. Metabolic profiles of snap-frozen thymomas (WHO types A, AB, B1, B2, B3, n = 12) and TCs ( n = 3) were determined by high resolution magic angle spinning 1H nuclear magnetic resonance (HRMAS 1H-NMR) spectroscopy. Metabolite-based prediction of active KEGG metabolic pathways was achieved with MetPA. In relation to metabolite-based metabolic pathways, gene expression signatures of TETs ( n = 115) were investigated in the public "The Cancer Genome Atlas" (TCGA) dataset using gene set enrichment analysis. Overall, thirty-seven metabolites were quantified in TETs, including acetylcholine that was not previously detected in other non-endocrine cancers. Metabolite-based cluster analysis distinguished clinically indolent (A, AB, B1) and aggressive TETs (B2, B3, TCs). Using MetPA, six KEGG metabolic pathways were predicted to be activated, including proline/arginine, glycolysis and glutathione pathways. The activated pathways as predicted by metabolite-profiling were generally enriched transcriptionally in the independent TCGA dataset. Shared high lactic acid and glutamine levels, together with associated gene expression signatures suggested a strong "Warburg effect", glutaminolysis and redox homeostasis as potential vulnerabilities that need validation in a large, independent cohort of aggressive TETs. If confirmed, targeting metabolic pathways may eventually prove as adjunct therapeutic options in TETs, since the metabolic features identified here are known to confer resistance to cisplatin-based chemotherapy, kinase inhibitors and immune checkpoint blockers, i.e., currently used therapies for non-resectable TETs.
- Published
- 2022
- Full Text
- View/download PDF
35. GTF2I Mutation in Thymomas: Independence From Racial-Ethnic Backgrounds. An Indian/German Comparative Study.
- Author
-
Jain D, Guleria P, Singh V, Parshad R, Kumar S, Gaiser T, Kurz KS, Ott G, Porubsky S, Preissler G, Sauer CG, Schölch S, Ströbel P, Hielscher T, Marx A, and Popovic ZV
- Subjects
- Adult, Aged, Female, Germany epidemiology, Humans, India epidemiology, Male, Middle Aged, Mutation, Myasthenia Gravis pathology, Race Factors, Thymoma epidemiology, Thymoma ethnology, Thymoma pathology, Thymus Neoplasms epidemiology, Thymus Neoplasms ethnology, Thymus Neoplasms pathology, Thymoma genetics, Thymus Neoplasms genetics, Transcription Factors, TFII genetics
- Abstract
Thymomas are the most frequent adult mediastinal cancers. Their etiology is unknown and their pathogenesis poorly understood. Racial, ethnic and environmental factors influence tumorigenesis in many cancers, but their role in thymomas remains unclear to date. In this study that included pretreatment thymoma cases from India and Germany ( n = 37 and n = 77, respectively) we compared i) the prevalence of the thymoma-specific chromosome 7 c.74146970T > A mutation of the GTF2I gene in type A and AB thymomas; ii) epidemiological features; and iii) the frequency of myasthenia gravis (MG). Due to a known predominance of GTF2I mutation in A and AB histotypes, we included only a marginal number of type B thymomas as a control group in both cohorts. While the distribution of histological types between the cohorts was similar ( p = 0.1622), Indian patients were strikingly younger ( p < 0.0001; median age 50 vs. 65 years) and showed significantly lower tumour stage (Masaoka-Koga stage I) at primary diagnosis ( p = 0.0005) than the German patients. In patients with known MG status ( n = 17 in Indian and n = 25 in German cohort), a clear trend towards more frequent MG was observed in the Indian group ( p = 0.0504; 48 vs. 82%). The prevalence of the GTF2I mutation (analysed in n = 34 Indian and n = 77 German patients) was identical in the two cohorts. We conclude that racial-ethnic and environmental factors do not significantly influence the most common molecular feature of thymomas but may have an impact on the timing of clinical presentation., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Jain, Guleria, Singh, Parshad, Kumar, Gaiser, Kurz, Ott, Porubsky, Preissler, Sauer, Schölch, Ströbel, Hielscher, Marx and Popovic.)
- Published
- 2021
- Full Text
- View/download PDF
36. Patient-Derived Organoids of Cholangiocarcinoma.
- Author
-
Maier CF, Zhu L, Nanduri LK, Kühn D, Kochall S, Thepkaysone ML, William D, Grützmann K, Klink B, Betge J, Weitz J, Rahbari NN, Reißfelder C, and Schölch S
- Subjects
- Adult, Aged, Aged, 80 and over, Animals, Antineoplastic Agents pharmacology, Bile Duct Neoplasms genetics, Cell Line, Tumor, Cholangiocarcinoma genetics, Female, Gene Expression Regulation, Neoplastic drug effects, High-Throughput Nucleotide Sequencing, Humans, Male, Mice, Middle Aged, Organ Culture Techniques methods, Organoids drug effects, Organoids pathology, Organoids transplantation, Precision Medicine, Sequence Analysis, RNA, Tumor Cells, Cultured, Exome Sequencing, Xenograft Model Antitumor Assays, Antineoplastic Agents administration & dosage, Bile Duct Neoplasms drug therapy, Bile Duct Neoplasms pathology, Biomarkers, Tumor genetics, Cholangiocarcinoma drug therapy, Cholangiocarcinoma pathology, Organoids cytology
- Abstract
Cholangiocarcinoma (CC) is an aggressive malignancy with an inferior prognosis due to limited systemic treatment options. As preclinical models such as CC cell lines are extremely rare, this manuscript reports a protocol of cholangiocarcinoma patient-derived organoid culture as well as a protocol for the transition of 3D organoid lines to 2D cell lines. Tissue samples of non-cancer bile duct and cholangiocarcinoma were obtained during surgical resection. Organoid lines were generated following a standardized protocol. 2D cell lines were generated from established organoid lines following a novel protocol. Subcutaneous and orthotopic patient-derived xenografts were generated from CC organoid lines, histologically examined, and treated using standard CC protocols. Therapeutic responses of organoids and 2D cell lines were examined using standard CC agents. Next-generation exome and RNA sequencing was performed on primary tumors and CC organoid lines. Patient-derived organoids closely recapitulated the original features of the primary tumors on multiple levels. Treatment experiments demonstrated that patient-derived organoids of cholangiocarcinoma and organoid-derived xenografts can be used for the evaluation of novel treatments and may therefore be used in personalized oncology approaches. In summary, this study establishes cholangiocarcinoma organoids and organoid-derived cell lines, thus expanding translational research resources of cholangiocarcinoma.
- Published
- 2021
- Full Text
- View/download PDF
37. [Postoperative hypocalcemia - the most common complication of endocrine head and neck surgery: acute management].
- Author
-
Lammert A, Nowak K, Weber R, Rotter N, Schölch S, Krämer BK, and Lammert A
- Subjects
- Humans, Parathyroid Glands surgery, Parathyroid Hormone, Postoperative Complications diagnosis, Postoperative Complications etiology, Postoperative Complications therapy, Thyroidectomy adverse effects, Hypocalcemia diagnosis, Hypocalcemia drug therapy, Hypocalcemia etiology, Hypoparathyroidism diagnosis, Hypoparathyroidism etiology, Hypoparathyroidism therapy
- Abstract
Background: In Germany, 8000 patients are affected by postoperative hypoparathyroidism per year following surgery of the thyroid gland, parathyroidal glands and the larynx. Patients do not only suffer from paresthesia in the acute phase of this complication, but are also adversely affected by the fear of loss of control following episodes of tetany even years after the first episode., Objectives: Discussion of a diagnostic pathway and presentation of a management pathway for postoperative hypocalcemia., Methods: Narrative review, analysis and discussion of current literature and expert recommendations., Results: Early determination of calcium and parathyroid hormone allows timely diagnosis and treatment of postoperative hypoparathyroidism. Active vitamin D is pivotal for the resorption of calcium. Only the combined treatment with active vitamin D and calcium can mitigate or prevent the postoperative drop of calcium levels., Conclusions: A standard operating procedure (SOP) for postoperative hypoparathyroidism should be implemented in every surgical department. An SOP for diagnosis and treatment of postoperative hypoparathyroidism is proposed for institutional individualization and implementation., Competing Interests: Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht., (Thieme. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
38. Diazo-Based Copolymers for the Wet Strength Improvement of Paper Based on Thermally Induced CH-Insertion Cross-Linking.
- Author
-
Schölch S, Schäfer JL, Meckel T, Brandstetter T, Biesalski M, and Rühe J
- Subjects
- Hydrophobic and Hydrophilic Interactions, Tensile Strength, Cellulose, Water
- Abstract
We present an alternative to commonly used, but from an environmental point of view, problematic wet strength agents, which are usually added to paper to prevent a loss of mechanical stability and finally disintegrate when they get into contact with water. To this end, diazoester-containing copolymers are generated, which are coated onto paper and by heating to 110-160 °C for short periods of time become activated and form carbene intermediates, which undergo a CH-insertion cross-linking reaction. The process leads to a simultaneous cross-linking of the polymer and its attachment to the cellulose substrate. The immobilization process of copolymers consisting of a hydrophilic matrix based on N , N -dimethylacrylamide and a diazoester-based comonomer to a cellulose model surface and to laboratory-engineered, fibrous paper substrates is investigated as a function of time, temperature, and cross-linker composition. The distribution of the polymer in the fiber network is studied using confocal fluorescence microscopy. Finally, the tensile properties of modified wet and dry eucalyptus sulfate papers are measured to demonstrate the strong effect of the thermally cross-linked copolymers on the wet strength of paper substrates. Initial experiments show that the tensile indices of the modified and wetted paper samples are up to 50 times higher compared to the values measured for unmodified samples. When dry and wet papers coated with the above-described wetting agents are compared, relative wet strengths of over 30% are observed.
- Published
- 2021
- Full Text
- View/download PDF
39. Differential Effects of Trp53 Alterations in Murine Colorectal Cancer.
- Author
-
Betzler AM, Nanduri LK, Hissa B, Blickensdörfer L, Muders MH, Roy J, Jesinghaus M, Steiger K, Weichert W, Kloor M, Klink B, Schroeder M, Mazzone M, Weitz J, Reissfelder C, Rahbari NN, and Schölch S
- Abstract
Background: Colorectal cancer (CRC) development is a multi-step process resulting in the accumulation of genetic alterations. Despite its high incidence, there are currently no mouse models that accurately recapitulate this process and mimic sporadic CRC. We aimed to develop and characterize a genetically engineered mouse model (GEMM) of Apc/Kras/Trp53 mutant CRC, the most frequent genetic subtype of CRC., Methods: Tumors were induced in mice with conditional mutations or knockouts in Apc, Kras, and Trp53 by a segmental adeno-cre viral infection, monitored via colonoscopy and characterized on multiple levels via immunohistochemistry and next-generation sequencing., Results: The model accurately recapitulates human colorectal carcinogenesis clinically, histologically and genetically. The Trp53 R172H hotspot mutation leads to significantly increased metastatic capacity. The effects of Trp53 alterations, as well as the response to treatment of this model, are similar to human CRC. Exome sequencing revealed spontaneous protein-modifying alterations in multiple CRC-related genes and oncogenic pathways, resulting in a genetic landscape resembling human CRC., Conclusions: This model realistically mimics human CRC in many aspects, allows new insights into the role of TP53 in CRC, enables highly predictive preclinical studies and demonstrates the value of GEMMs in current translational cancer research and drug development.
- Published
- 2021
- Full Text
- View/download PDF
40. Robot-assisted training after proximal humeral fracture: A randomised controlled multicentre intervention trial.
- Author
-
Kröger I, Nerz C, Schwickert L, Schölch S, Müßig JA, Studier-Fischer S, Nolte PC, Becker C, and Augat P
- Subjects
- Adult, Aged, Cost-Benefit Analysis, Female, Germany, Humans, Male, Middle Aged, Occupational Therapy methods, Prospective Studies, Range of Motion, Articular, Robotics methods, Shoulder Fractures physiopathology, Shoulder Fractures surgery, Surveys and Questionnaires, Treatment Outcome, Physical Therapy Modalities, Shoulder Fractures rehabilitation
- Abstract
Objective: To examine whether robotic-assisted training as a supplement to usual therapy is safe, acceptable and improves function and patient reported outcome after proximal humeral fractures (PHF)., Design: Multicentre, assessor-blinded, randomised controlled prospective trial., Setting: Three different rehabilitation hospitals in Germany., Subjects: In total 928 PHF patients between 35 and 70 years were screened. Forty-eight participants were included in the study (intervention group n = 23; control group n = 25)., Intervention: The control group received usual occupational and physiotherapy over three weeks, and the intervention group received additional 12 robot-assisted training sessions at the ARMEO
® -Spring., Main Measures: Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH), the Wolf Motor Function Test-Orthopaedic, active range of motion and grip strength were determined before and after intervention period. The DASH was additionally obtained postal 6 and 13 months following surgery., Results: The mean age of participants was 55 ± 10 years and was similar in both groups ( p > 0.05). The change in DASH as the primary endpoint in the intervention group after intervention was -15 (CI = 8-22), at follow-up six month -7 (CI = -2 to 16) at follow up 13 month -9 (CI = 1-16); in control group -14 (CI = 11-18), at follow-up six month -13 (CI = 7-19) at follow up 13 month -6 (CI = -3 to 14). No difference in the change was found between groups ( p > 0.05). None of the follow-up time points demonstrated an additional benefit of the robotic therapy., Conclusion: The additional robot-assisted therapy was safe, acceptable but showed no improvement in functional shoulder outcome compared to usual therapy only.- Published
- 2021
- Full Text
- View/download PDF
41. Molecular pathology of thymomas: implications for diagnosis and therapy.
- Author
-
Marx A, Belharazem D, Lee DH, Popovic ZV, Reißfelder C, Schalke B, Schölch S, Ströbel P, Weis CA, and Yamada Y
- Subjects
- Biomarkers, Tumor genetics, Biomarkers, Tumor metabolism, DNA Mutational Analysis, Humans, Pathology, Molecular, Thymoma genetics, Thymoma metabolism, Thymoma pathology, Thymus Neoplasms genetics, Thymus Neoplasms metabolism, Thymus Neoplasms pathology, Mutation, Thymoma diagnosis, Thymus Neoplasms diagnosis
- Abstract
Thymomas exhibit a unique genomic landscape, comprising the lowest on average total mutational burden among adult human cancers; a unique point mutation in the GTF2I gene in WHO type A and AB thymomas (and rarely others); almost unique KMT2A-MAML2 translocations in rare WHO type B2 and B3 thymomas; a unique YAP1-MAML2 translocation in almost all metaplastic thymomas; and unique miRNA profiles in relation to GTF2I mutational status and WHO histotypes. While most thymomas can be diagnosed solely on the basis of morphological features, mutational analyses can solve challenging differential diagnostic problems. No molecular biomarkers have been identified that predict the response of unresectable thymomas to chemotherapy or agents with known molecular targets. Despite the common and strong expression of PDL1 in thymomas, immune checkpoint inhibitors are rarely applicable due to the poor predictability of common, life-threatening autoimmune side effects that are related to the unrivaled propensity of thymomas towards autoimmunity.
- Published
- 2021
- Full Text
- View/download PDF
42. GAS2L1 Is a Potential Biomarker of Circulating Tumor Cells in Pancreatic Cancer.
- Author
-
Zhu L, Kan KJ, Grün JL, Hissa B, Yang C, Győrffy B, Loges S, Reißfelder C, and Schölch S
- Abstract
Pancreatic cancer is a malignant disease with high mortality and a dismal prognosis. Circulating tumor cell (CTC) detection and characterization have emerged as essential techniques for early detection, prognostication, and liquid biopsy in many solid malignancies. Unfortunately, due to the low EPCAM expression in pancreatic cancer CTCs, no specific marker is available to identify and isolate this rare cell population. This study analyzed single-cell RNA sequencing profiles of pancreatic CTCs from a genetically engineered mouse model (GEMM) and pancreatic cancer patients. Through dimensionality reduction analysis, murine pancreatic CTCs were grouped into three clusters with different biological functions. CLIC4 and GAS2L1 were shown to be overexpressed in pancreatic CTCs in comparison with peripheral blood mononuclear cells (PBMCs). Further analyses of PBMCs and RNA-sequencing datasets of enriched pancreatic CTCs were used to validate the overexpression of GAS2L1 in pancreatic CTCs. A combinatorial approach using both GAS2L1 and EPCAM expression leads to an increased detection rate of CTCs in PDAC in both GEMM and patient samples. GAS2L1 is thus proposed as a novel biomarker of pancreatic cancer CTCs.
- Published
- 2020
- Full Text
- View/download PDF
43. Characterization of Stem-like Circulating Tumor Cells in Pancreatic Cancer.
- Author
-
Zhu L, Hissa B, Győrffy B, Jann JC, Yang C, Reissfelder C, and Schölch S
- Abstract
Pancreatic ductal adenocarcinoma (PDAC) is the fourth most frequent cause of death from cancer. Circulating tumor cells (CTCs) with stem-like characteristics lead to distant metastases and thus contribute to the dismal prognosis of PDAC. Our purpose is to investigate the role of stemness in CTCs derived from a genetically engineered mouse model of PDAC and to further explore the potential molecular mechanisms. The publically available RNA sequencing dataset GSE51372 was analyzed, and CTCs with (CTC-S) or without (CTC-N) stem-like features were discriminated based on a principal component analysis (PCA). Differentially expressed genes, weighted gene co-expression network analysis (WGCNA), and further functional enrichment analyses were performed. The prognostic role of the candidate gene ( CTNNB1 ) was assessed in a clinical PDAC patient cohort. Overexpression of the pluripotency marker Klf4 (Krüppel-like factor 4) in CTC-S cells positively correlates with Ctnnb1 (β-Catenin) expression, and their interaction presumably happens via protein-protein binding in the nucleus. As a result, the adherens junction pathway is significantly enriched in CTC-S. Furthermore, the overexpression of Ctnnb1 is a negative prognostic factor for progression-free survival (PFS) and relapse-free survival (RFS) in human PDAC cohort. Overexpression of Ctnnb1 may thus promote the metastatic capabilities of CTCs with stem-like properties via adherens junctions in murine PDAC., Competing Interests: The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
- Published
- 2020
- Full Text
- View/download PDF
44. The prognostic role of circulating tumor cells in colorectal cancer.
- Author
-
Nanduri LK, Hissa B, Weitz J, Schölch S, and Bork U
- Subjects
- Animals, Colorectal Neoplasms diagnosis, Humans, Microfluidic Analytical Techniques methods, Neoplasm Metastasis, Neoplasm Recurrence, Local, Prognosis, Survival, Biomarkers, Tumor blood, Colorectal Neoplasms pathology, Neoplastic Cells, Circulating metabolism
- Abstract
Introduction : Metastasis is the main cause of cancer-associated death in colorectal cancer (CRC). The presence of circulating tumor cells (CTC) in the blood is associated with an increased risk of recurrence and poor prognosis. The clinical significance of CTCs as a novel biomarker has been extensively studied in the last decade. It has been shown that CTC detection applies to early cancer detection. The presence of CTCs is associated with metastatic spread and poor survival and is also useful as a marker for therapy response. Areas covered : We summarize the role of CTC in CRC, their clinical significance, current methods for CTC detection and challenges as well as future perspectives of CTC research. Expert commentary : The clinical significance of CTC in CRC patients is well established. Although insightful, the available marker-based approaches hampered our understanding of the CTCs and their biology, as such approaches do not take into account the heterogeneity of these cell populations. New technologies should expand the marker-based detection to multi biomarker-based approaches together with recent technological advances in microfluidics for single cell enrichment and analysis.
- Published
- 2019
- Full Text
- View/download PDF
45. Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations.
- Author
-
Seidlitz T, Chen YT, Uhlemann H, Schölch S, Kochall S, Merker SR, Klimova A, Hennig A, Schweitzer C, Pape K, Baretton GB, Welsch T, Aust DE, Weitz J, Koo BK, and Stange DE
- Subjects
- Adenomatous Polyposis Coli Protein genetics, Animals, Annexins genetics, Antineoplastic Agents pharmacology, Antineoplastic Agents therapeutic use, Cell Transformation, Neoplastic genetics, Drug Resistance, Neoplasm genetics, Female, Humans, Integrases genetics, Male, Mice, Mice, Transgenic, Mutation, Proto-Oncogene Proteins p21(ras) genetics, Smad4 Protein genetics, Stomach Neoplasms drug therapy, Stomach Neoplasms pathology, Tumor Suppressor Protein p53 genetics, Disease Models, Animal, Gastric Mucosa pathology, Genetic Loci genetics, Stomach Neoplasms genetics
- Abstract
Background & Aims: Patterns of genetic alterations characterize different molecular subtypes of human gastric cancer. We aimed to establish mouse models of these subtypes., Methods: We searched databases to identify genes with unique expression in the stomach epithelium, resulting in the identification of Anxa10. We generated mice with tamoxifen-inducible Cre recombinase (CreERT2) in the Anxa10 gene locus. We created 3 mouse models with alterations in pathways that characterize the chromosomal instability (CIN) and the genomically stable (GS) subtypes of human gastric cancer: Anxa10-CreER
T2 ;KrasG12D/+ ;Tp53R172H/+ ;Smad4fl/f (CIN mice), Anxa10-CreERT2 ;Cdh1fl/fl ;KrasG12D/+ ;Smad4fl/fl (GS-TGBF mice), and Anxa10-CreERT2 ;Cdh1fl/fl ;KrasG12D/+ ;Apcfl/fl (GS-Wnt mice). We analyzed tumors that developed in these mice by histology for cell types and metastatic potential. We derived organoids from the tumors and tested their response to chemotherapeutic agents and the epithelial growth factor receptor signaling pathway inhibitor trametinib., Results: The gastric tumors from the CIN mice had an invasive phenotype and formed liver and lung metastases. The tumor cells had a glandular morphology, similar to human intestinal-type gastric cancer. The gastric tumors from the GS-TGFB mice were poorly differentiated with diffuse morphology and signet ring cells, resembling human diffuse-type gastric cancer. Cells from these tumors were invasive, and mice developed peritoneal carcinomatosis and lung metastases. GS-Wnt mice developed adenomatous tooth-like gastric cancer. Organoids derived from tumors of GS-TGBF and GS-Wnt mice were more resistant to docetaxel, whereas organoids from the CIN tumors were more resistant to trametinib., Conclusions: Using a stomach-specific CreERT2 system, we created mice that develop tumors with morphologic similarities to subtypes of human gastric cancer. These tumors have different patterns of local growth, metastasis, and response to therapeutic agents. They can be used to study different subtypes of human gastric cancer., (Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
46. The overall potential of CD47 in cancer immunotherapy: with a focus on gastrointestinal tumors.
- Author
-
Tzatzarakis E, Hissa B, Reissfelder C, and Schölch S
- Subjects
- Animals, Gastrointestinal Neoplasms immunology, Gastrointestinal Neoplasms pathology, Humans, Neoplastic Cells, Circulating metabolism, Neoplastic Stem Cells metabolism, Prognosis, CD47 Antigen immunology, Gastrointestinal Neoplasms therapy, Immunotherapy methods
- Abstract
Introduction : CD47 is an anti-phagocytic ('don't eat me') signal overexpressed in many malignant diseases. It acts as myeloid immune checkpoint and thus has prognostic and therapeutic implications. Areas covered : This review presents and discusses the currently available data on the prognostic role and therapeutic value of CD47 in gastrointestinal tumors. Expert opinion : CD47 is overexpressed on the great majority of gastrointestinal tumors, cancer stem cells and circulating tumor cells. Overexpression of CD47 usually predicts a negative prognosis and seems to contribute to cancer immune evasion. The inhibition of CD47 has shown impressive results in clinical trials in hematologic malignancies. However, for gastrointestinal tumors only preclinical data is available. Inhibition of this myeloid immune checkpoint may yield great clinical benefit due to the abundance of myeloid effector cells. However, due to the ubiquitous expression of CD47 and the resulting antigen sink, vast amounts of antibody are required in order to reach therapeutic concentrations. QPCTL inhibitors blocking post-translational modification of CD47 protein may be a solution to this problem.
- Published
- 2019
- Full Text
- View/download PDF
47. Successful treatment of gastric necrosis after ingestion of hydrochloric acid: a two-stage minimally invasive surgical procedure.
- Author
-
Rasbach E, Schölch S, Reissfelder C, and Rahbari NN
- Subjects
- Adult, Anastomosis, Roux-en-Y, Diagnosis, Differential, Gastrectomy, Humans, Male, Minimally Invasive Surgical Procedures, Necrosis chemically induced, Necrosis surgery, Robotic Surgical Procedures, Suicide, Attempted, Gastric Mucosa injuries, Gastric Mucosa surgery, Hydrochloric Acid poisoning
- Abstract
Caustic ingestion may cause devastating injuries of the upper gastrointestinal tract and the respiratory system. We report here the successful treatment of a 37-year-old patient who ingested hydrochloric acid (100 mL; 24%) in suicidal intention. An oesophagogastroduodenoscopy revealed extensive necrosis of the gastric mucosa. A diagnostic laparoscopy was performed and confirmed the suspected transmural necrosis which resulted in a discontinuous laparoscopic gastrectomy. During the next days, the oesophageal stump was monitored through frequent oesophagoscopies and showed a good recovery. Thus, it was possible to restore continuity as early as by the sixth postoperative day performing a roux-en-y oesophagojejunostomy using the da Vinci Xi surgical robot. The patient underwent all procedures without any surgical complications and was discharged almost 1 month after initial presentation in good general condition., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
48. Correction: A more physiological approach to lipid metabolism alterations in cancer: CRC-like organoids assessment.
- Author
-
Cruz-Gil S, Sánchez-Martínez R, Wagner-Reguero S, Stange D, Schölch S, Pape K, and Molina AR
- Abstract
[This corrects the article DOI: 10.1371/journal.pone.0219944.].
- Published
- 2019
- Full Text
- View/download PDF
49. Prognostic value of DLGAP5 in colorectal cancer.
- Author
-
Branchi V, García SA, Radhakrishnan P, Győrffy B, Hissa B, Schneider M, Reißfelder C, and Schölch S
- Subjects
- Adult, Aged, Aged, 80 and over, Cell Line, Tumor, Cell Movement, Cell Proliferation, Chromosomal Instability, Colorectal Neoplasms pathology, Female, Humans, Intestines pathology, Lymph Nodes pathology, Male, Middle Aged, Neoplasm Invasiveness, Neoplasm Recurrence, Local pathology, Prognosis, Stem Cells metabolism, Survival Analysis, Colorectal Neoplasms metabolism, Neoplasm Proteins metabolism
- Abstract
Purpose: DLG7 (disc large homolog 7) is a microtubule-associated protein encoded by DLGAP5 (DLG associated protein 5) gene and has an important role during spindle assembly. Spindle assembly deregulation is a well-known cause of genomic instability. The aim of this study was to investigate the influence of DLGAP5 expression on survival and to evaluate its potential use as a biomarker in colorectal cancer (CRC)., Methods: DLGAP5 expression was measured in the primary tumor and corresponding normal mucosa samples from 109 patients with CRC and correlated to clinical and pathological data. The results were validated in a second, publically available patient cohort. Molecular effects of DLG7/DLGAP5 in CRC were analyzed via functional assays in knockdown cell lines., Results: DLGAP5 downregulation led to a significant reduction of the invasion and migration potential in CRC. In addition, DLGAP5 expression correlates with nodal status and advanced UICC stage (III-IV).Subgroup analyses revealed a correlation between DLGAP5 overexpression and poor survival in patients with non-metastatic disease (M0). Furthermore, overexpression of DLGAP5 is associated with worse overall survival in distinct molecular CRC subtypes., Conclusions: The results of this study suggest the importance of DLGAP5 in defining a more aggressive CRC phenotype. DLG7/DLGAP5 represents a potential biomarker for CRC in molecular subgroups of CRC.
- Published
- 2019
- Full Text
- View/download PDF
50. Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer.
- Author
-
Schölch S, Bogner A, Bork U, Rahbari M, Győrffy B, Schneider M, Reissfelder C, Weitz J, and Rahbari NN
- Subjects
- Aged, Biomarkers, Tumor blood, Colorectal Neoplasms pathology, Colorectal Neoplasms therapy, Disease-Free Survival, Female, Humans, Male, Neoplasm Staging, Prognosis, Retrospective Studies, Colorectal Neoplasms diagnosis, Epidermal Growth Factor blood, Placenta Growth Factor blood
- Abstract
The aim of this study was to determine the prognostic value of circulating angiogenic cytokines in non-metastatic colorectal cancer (CRC) patients. Preoperative serum samples of a training (TC) (n = 219) and a validation cohort (VC) (n = 168) were analyzed via ELISA to determine PlGF, EGF, VEGF, Ang1, PDGF-A, PDGF-B, IL-8 and bFGF levels. In addition, survival was correlated with PlGF and EGF expression measured by microarray and RNAseq in two publicly available, independent cohorts (n = 550 and n = 463, respectively). Prognostic values for overall (OS) and disease-free survival (DFS) were determined using uni- and multivariate Cox proportional hazard analyses. Elevated PlGF is predictive for impaired OS (TC: HR 1.056; p = 0.046; VC: HR 1.093; p = 0.001) and DFS (TC: HR 1.052; p = 0.029; VC: HR 1.091; p = 0.009). Conversely, elevated EGF is associated with favorable DFS (TC: HR 0.998; p = 0.045; VC: HR 0.998; p = 0.018) but not OS (TC: p = 0.201; VC: p = 0.453). None of the other angiogenic cytokines correlated with prognosis. The prognostic value of PlGF (OS + DFS) and EGF (DFS) was confirmed in both independent retrospective cohorts. Serum PlGF and EGF may serve as prognostic markers in non-metastatic CRC.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.